Trial Profile

A two-year extension to a one-year, multicenter, open-label, randomised study to evaluate the safety and efficacy of FTY720 combined with tacrolimus and steroids versus mycophenolate mofetyl combined with tacrolimus and steroids, in de novo adult renal transplant recipients.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 15 Jul 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Fingolimod (Primary) ; Mycophenolate mofetil (Primary) ; Corticosteroids; Tacrolimus
Indications Renal transplant rejection
Focus Therapeutic Use
Sponsors Novartis

01 Nov 2011 Actual end date (Dec 2005) added as reported by ClinicalTrials.gov.
17 Dec 2005 New trial record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com